Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study - PubMed (original) (raw)
Comparative Study
. 2005 Mar 15;103(6):1265-73.
doi: 10.1002/cncr.20909.
Affiliations
- PMID: 15712203
- DOI: 10.1002/cncr.20909
Free article
Comparative Study
Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study
Shioto Suzuki et al. Cancer. 2005.
Free article
Abstract
Background: Recently, molecular therapies targeting epidermal growth factor receptor (EGFR) have been developed for clinical use. The current study was conducted to determine 1) the exact frequency of EGFR protein overexpression, 2) the correlation between protein overexpression and EGFR amplification, and 3) the correlation between the status of the genetic and clinicopathologic features in nonsmall cell lung carcinomas (NSCLC).
Methods: In total, 181 NSCLC samples were examined immunohistochemically using an antibody against EGFR, and tumor cells that exhibited overexpression were examined further for EGFR amplification by fluorescence in situ hybridization.
Results: Overexpression of EGFR protein was found in 34% of the tumors. Among these, EGFR amplification was demonstrated in 74%. High-level gene amplification was found exclusively in tumors cells with high protein expression. In most of these tumors, cells that exhibited EGFR overexpression and gene amplification were distributed heterogeneously, even within a single tumor nodule. Statistically, EGFR overexpression was correlated significantly with lymph node metastasis and with a more advanced pathologic stage. Moreover, in adenocarcinomas, gene amplification was correlated significantly with lymph node metastasis and tended to be correlated with a more advanced pathologic stage.
Conclusions: The overexpression of EGFR in NSCLC was accompanied predominantly, but not exclusively, by gene amplification. It is important to evaluate not only protein overexpression but also the EGFR status to design adjuvant therapies for patients with NSCLC, because specimens that exhibit both protein overexpression and gene amplification may predict eventual lymph node metastasis and, possibly, aggressive tumor behavior.
Similar articles
- Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ, Xu X, Choe G, Chung DH, Seo JW, Lee JH, Lee CT, Jheon S, Sung SW, Chung JH. Lee HJ, et al. Lung Cancer. 2010 Jun;68(3):375-82. doi: 10.1016/j.lungcan.2009.07.014. Epub 2009 Aug 26. Lung Cancer. 2010. PMID: 19712993 - Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
Dacic S, Flanagan M, Cieply K, Ramalingam S, Luketich J, Belani C, Yousem SA. Dacic S, et al. Am J Clin Pathol. 2006 Jun;125(6):860-5. doi: 10.1309/H5UW-6CPC-WWC9-2241. Am J Clin Pathol. 2006. PMID: 16690485 - Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
Suzuki M, Shigematsu H, Iizasa T, Hiroshima K, Nakatani Y, Minna JD, Gazdar AF, Fujisawa T. Suzuki M, et al. Cancer. 2006 May 15;106(10):2200-7. doi: 10.1002/cncr.21853. Cancer. 2006. PMID: 16598760 - The biology of epidermal growth factor receptor in lung cancer.
Scagliotti GV, Selvaggi G, Novello S, Hirsch FR. Scagliotti GV, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4227s-4232s. doi: 10.1158/1078-0432.CCR-040007. Clin Cancer Res. 2004. PMID: 15217963 Review. - The emerging role of biomarkers in advanced non-small-cell lung cancer.
Socinski MA. Socinski MA. Clin Lung Cancer. 2010 May;11(3):149-59. doi: 10.3816/CLC.2010.n.019. Clin Lung Cancer. 2010. PMID: 20439190 Review.
Cited by
- Increased EGFR mRNA Expression Levels in Non-Small Cell Lung Cancer.
Tasdemir S, Taheri S, Akalin H, Kontas O, Onal O, Ozkul Y. Tasdemir S, et al. Eurasian J Med. 2019 Jun;51(2):177-185. doi: 10.5152/eurasianjmed.2016.0237. Epub 2017 Jan 25. Eurasian J Med. 2019. PMID: 31258360 Free PMC article. - Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas.
Gwak GY, Yoon JH, Shin CM, Ahn YJ, Chung JK, Kim YA, Kim TY, Lee HS. Gwak GY, et al. J Cancer Res Clin Oncol. 2005 Oct;131(10):649-52. doi: 10.1007/s00432-005-0016-1. Epub 2005 Oct 20. J Cancer Res Clin Oncol. 2005. PMID: 16032426 - Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules.
Chen W, Shen B, Sun X. Chen W, et al. Mol Imaging. 2019 Jan-Dec;18:1536012118823473. doi: 10.1177/1536012118823473. Mol Imaging. 2019. PMID: 30799684 Free PMC article. Review. - Pathologic nodal metastasis assessment using tumour-derived molecular features in patients with lung adenocarcinoma.
Wang S, Zhou Z, Wang S, Guo R, Ma Z, Zhao D, Wang L, Liu Y, Ma Y, Zhang J, Wang S, Chen Y, Ou Q, Chen J. Wang S, et al. Clin Transl Med. 2024 Apr;14(4):e1638. doi: 10.1002/ctm2.1638. Clin Transl Med. 2024. PMID: 38558516 Free PMC article. No abstract available. - PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis.
Chen QY, Costa M. Chen QY, et al. Mol Pharmacol. 2018 Jul;94(1):784-792. doi: 10.1124/mol.118.112268. Epub 2018 May 16. Mol Pharmacol. 2018. PMID: 29769245 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous